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Abstract
Background: Onchocerciasis, an infection caused by the filarial nematode Onchocerca volvulus, is a major public health
concern. Given the debilitating symptoms associated with onchocerciasis and concerns about recrudescence in areas of
previous onchocerciasis control, more efficient tools are needed for diagnosis and monitoring of control measures. We
investigated whether luciferase immunoprecipitation systems (LIPS) may be used as a more rapid, specific, and standardized
diagnostic assay for Onchocerca volvulus infection.
Methods: Four recombinantly produced Onchocerca volvulus antigens (Ov-FAR-1, Ov-API-1, Ov-MSA-1 and Ov-CPI-1) were
tested by LIPS on a large cohort of blinded sera comprised of both uninfected controls and patients with a proven parasitic
infection including Onchocerca volvulus (Ov), Wuchereria bancrofti (Wb), Loa loa (Ll), Strongyloides stercoralis (Ss), and with
other potentially cross-reactive infections. In addition to testing all four Ov antigens separately, a mixture that tested all four
antigens simultaneously was evaluated in the standard 2-hour incubation format as well as in a 15-minute rapid LIPS format.
Findings: Antibody responses to the four different Ov antigens allowed for unequivocal differentiation between Ov-infected
and uninfected control sera with 100% sensitivity and 100% specificity. Analysis of the antibody titers to each of these four
antigens in individual Ov-infected sera revealed that they were markedly different and did not correlate (rS=–0.11 to 0.58;
P=0.001 to 0.89) to each other. Compared to Ov-infected sera, patients infected with Wb, Ll, Ss, and other conditions had
markedly lower geometric mean antibody titers to each of the Ov 4 antigens (P,0.0002 for each antigen). The simplified
method of using a mixture of the 4 Ov antigens simultaneously in the standard format or a quick 15-minute format (QLIPS)
showed 100% sensitivity and 100% specificity in distinguishing the Ov-infected sera from the uninfected control sera.
Finally, the QLIPS format had the best performance with 100% sensitivity and specificity values of 76%, 84% and 93% for
distinguishing Ov from Wb, Ll and Ss-infected sera.
Conclusions: The multi-antigen LIPS assay can be used as a rapid, high throughput, and specific tool to not only to diagnose
individual Ov infections but also as a sensitive and potentially point-of-care method for early detection of recrudescent
infections in areas under control and for mapping new areas of transmission of Ov infection.
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Introduction
As one of the neglected tropical diseases (NTDs), onchocerciasis
(or ‘river blindness’), caused by the filarial parasite Onchocerca volvulus
(Ov),can leadtoblindness and disabling dermatitis. Pastandongoing
control measures, aimed at interrupting transmission by vector
control (Onchocerciasis Control Programme in West Africa, OCP),
reducing the burden of morbidity to tolerable levels (African
Programme for Onchocerciasis Control, APOC), and eliminating
the reservoir of infection wherever possible (Onchocerciasis
Elimination Program for the Americas, OEPA), have led to
substantial decreases in the prevalence of infection and the risk of
blindness [1]. Despite these measures, which currently rely almost
exclusively on ivermectin distribution, estimates suggest that 37
million people remain infected with Ov with an additional 90 million
people being at risk in Africa [2]. Superimposed on this estimate of
Ov-infected individuals has been the concern about ivermectin
resistance [3] and the serious adverse events associated with
ivermectin administration in areas where another filarial parasite,
Loa loa, is co-endemic [4].
In support of elimination programs for onchocerciasis, various
criteria for elimination have been proposed that rely on sensitive
molecular xenomonitoring of infection in the Simulium vectors,
epidemiologic and clinical criteria, and proven diagnostic
assessments [5]. For the diagnostics in support of certification
programs for onchocerciasis elimination, detection of microfilariae
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serodiagnostic assays [6] have largely supplanted skin snipping
because these antibody-based tests are less invasive, more sensitive
and can detect pre-patent infection [7]. A variety of serological tests
employing different Ovantigenshave beendescribed (reviewedin[8]
including those that have used cocktails of antigens [9,10,11]. Each
antigen, when tested, has had the characteristic of identifying Ov
infection early (often pre-patency) in the infection. More recently a
field-applicable diagnostic immunoassay based on one of these Ov-
specific recombinant antigens, Ov-16, showed 80% sensitivity for
detecting Ov-infected sera [12,13], while an ELISA employing a
recombinant hybrid Ov protein showed 93% sensitivity [14,15].
Despite the high sensitivity of all these immunoassays, each of these
tests have had some difficulty discriminating Ov-infected sera from
some other filarial infections that can be co-endemic with O. volvulus
such as Wuchereria bancrofti (a causal agent of lymphatic filariasis) and
L. loa (the causal agent of loiasis).
Recently, Renilla luciferase (Ruc)-antigen fusions produced in
Cos1 cells were used in a simple immunoprecipitation assay called
LIPS (denoting luciferase immunoprecipitation systems) to mea-
sure antibody responses to infections by the intestinal nematode
Strongyloides stercoralis (Ss) [16] and the filarial nematode L. loa (Ll)
[17]. In these studies, LIPS showed improved performance to
existing ELISAs and offered a highly sensitive, robust and high-
throughput testing format. In the present study, we utilized the
LIPS technology for the assessment of Ov-specific antibodies. The
results presented here demonstrate that LIPS assay detection of
antibodies to a four-antigen cocktail in a standard 2-hour format
or with a rapid 15-minute LIPS test (so-called QLIPS, for quick
LIPS) generates a highly robust, sensitive and specific test for
identifying O. volvulus infection.
Materials and Methods
Ethics statement
Informed written consent was obtained from all subjects in
accordance with the human experimentation guidelines of the
Department of Health and Human Services under multiple
NIAID IRB-approved protocols, and the studies were conducted
according to the principles expressed in the Declaration of
Helsinki. All patient identification codes have been removed in
this publication.
Human sera
For the present study, great care was taken to choose sera from
areas where there was no overlap between onchocerciasis and
other filarial infections. Thus, pre-treatment sera were taken from
well-characterized (O. volvulus microfilaria-positive, MF+) patients
with onchocerciasis from Ecuador and Guatemala [18]. Sera from
patients with documented Wuchereria bancrofti (W. bancrofti MF+ and
circulating filarial antigen positive) were obtained from India,
Guyana, the Comoros Islands and the Cook Islands, those with
loiasis (L. loa MF+) from an area of Benin where there is no or W.
bancrofti or O. volvulus [18], and those with strongyloidiasis (S.
stercoralis larvae in fecal samples) [16] from Southeast Asia.
Additional sera came from well-characterized patients seen by
the Clinical Parasitology Unit, Laboratory of Parasitic Diseases,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health. Some of these sera included four with Hyper-
IgE syndrome (HIE), four with Hypereosinophilic syndrome
(HES), as well as four others with non-filarial parasitic infections.
Control uninfected sera came from North American subjects with
no history of exposure to filarial or other nematode parasites and
who had never traveled out of North America. A more detailed
summary of the patient sera used is shown in Table 1.
Generation of Ruc-antigen fusion constructs
A mammalian Renilla luciferase (Ruc) expression vector,
pREN2, was used to generate all plasmids [19,20]. The four Ov
antigens used in the LIPS assays included fatty-acid and retinol-
binding protein-1, Ov-Far-1/Ov-20 [21]; aspartyl protease
inhibitor, Ov-API-1/Ov-33 [22]; microfilariae surface-associated
protein, Ov-MSA-1/Ov103 [23]; and the cysteine proteinase
inhibitor, Ov-CPI-1/Ov10/OC 9.3/Ov7 [24,25,26]. For each
antigen, synthetic DNA optimized for mammalian codon usage
Table 1. Patient population for serologic studies.
Group Source of population No.
Control United States 72
Onchocerciasis (MF+) Guatemala 11
Ecuador 21
Cameroon* 4
Sierra Leone 2
Loiasis (MF+) Benin 90
Wuchereria bancrofti (MF+) Cook Islands 3
Comoros Islands 2
Guyana 1
India 84
Strongyloides stercoralis SE Asia 27
Miscellaneous Hyper-IgE syndrome (HIE) 4
Hypereosinophilic syndrome (HES) 4
Non-filarial parasitic infections 4
*Negative for daytime microfilariae of Loa loa and negative for W. bancrofti
circulating filarial antigen.
doi:10.1371/journal.pntd.0000438.t001
Author Summary
Caused by the filarial parasite Onchocerca volvulus,
onchocerciasis is a neglected tropical disease associated
with blindness and severe dermatitis. Available diagnostic
methods are either invasive, require hours or days to
perform, and/or need sophisticated equipment to be
conducted. Thus, there is an urgent need for simple and
rapid technologies for the specific diagnosis of Onchocerca
volvulus infection. Here we investigated whether luciferase
immunoprecipitation systems (LIPS) can produce a more
rapid and specific test for diagnosis of O. volvulus infection.
Using modified versions of previously identified Onchocer-
ca-specific antigens, LIPS tests detected antibodies to all
four O. volvulus antigens and easily distinguished the O.
volvulus-infected samples from uninfected samples. We
also tested these four different antigens in a simpler
format as a combined mixture and distinguished 100% of
the confirmed cases from the uninfected controls. A rapid
15-minute version of this mixture test (QLIPS) also allowed
distinction of 100% of the cases from those uninfected and
performed even better in identifying Onchocerca from
other cross-reactive parasitic infections. This study sug-
gests that this rapid LIPS test (QLIPS) has the potential to
be used in point-of-care detection of onchocerciasis and
thereby may provide a new tool for diagnosis and the
monitoring of transmission control measures.
Diagnosis of Onchocerciasis
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length protein minus the amino acid residues for the signal
sequence. Specifically, the fusion proteins used for Ov-Far-1, Ov-
API-1, Ov-MSA-1 and Ov-CPI-1 were derived from amino acids
18-178, 18-235, 18-158 and 54-162, respectively, of full-length
proteins. Additional details of the nucleotide and amino acid
sequences can be found in the GenBank database with accession
numbers FJ561736, FJ561737, FJ561735, and FJ561734 for Ov-
FAR-1, Ov-API-1, Ov-MSA-1, and Ov-CPI-1, respectively. The
four Ov templates were amplified by PCR with gene specific linker-
primer adapters. In each case, the cDNA fragments were
subcloned downstream of Ruc, and a stop codon was included
directly after the protein fragment of interest. The PCR primer
sequences that were used to generate each construct are as follows:
Ov-FAR-1, 59-GAGGGATCCAACGTGGTGCCCTTCTCC-39
and 59-GAGCTCGAGTCAGTTCTT CTGCAGAAA-39; Ov-
API-1, 59-GAGGGATCCGGAG TGGTGAAGAGATAC-39
and 59-GAGCTCGAGTCAGTAGATGGCCACGCA39; Ov-
MSA-1, 59-GAGGGATCCGACCTGCT GTCAGAGGCC-39
and 59-GAGCTCGAGTCAT T CCCTCAGAGTATT-39; and
Ov-CPI-1, 59-GAGGGATCCGGCTGGGAGGATAGAGAC-39
and 59-GAGCTCGAGTCACACCTC CTTTGTGCC-39. The
integrity of all the plasmid constructs was confirmed by DNA
sequencing.
LIPS analysis
LIPS tests were performed in a blinded manner on a large
number of sera (see Table 1) at room temperature using a 96-well
plate format [27]. First, a ‘‘master plate’’ was constructed by
diluting patient sera 1:10 in assay buffer A (20 mM Tris, pH 7.5,
150 mM NaCl, 5 mM MgCl2, 1% Triton X-100) in a 96-well
polypropylene microtitration plate. To evaluate antibody titers by
LIPS, 40 ml of buffer A, 10 ml of diluted human sera (1 ml
equivalent), and 50 mlo f1 610
7 light units (LU) of Ruc-antigen
Cos1 cell extract, diluted in buffer A, were added to each well of a
polypropylene plate and incubated for 1 hour at room tempera-
ture. Next, 7 ml of a 30% suspension of Ultralink protein A/G
beads (Pierce Biotechnology, Rockford, IL) in PBS was added to
the bottom of each well of a 96-well filter HTS plate (Millipore,
Bedford, MA). The 100-ml antigen-antibody reaction mixture was
then transferred to this filter plate and incubated for 1 hour at
room temperature on a rotary shaker. The protein bound to the
protein A/G beads was washed using a vacuum manifold. After
the final wash, LU were measured in a Berthold LB 960 Centro
microplate luminometer (Berthold Technologies, Bad Wilbad,
Germany) using coelenterazine substrate mix (Promega, Madi-
son,WI). All the LU data shown represent the average of two
independent experiments and were corrected for background LU
values of the beads incubated with Ruc-antigen extract but
without sera. An input of 10 million LU for each antigen was used
in both the individual tests and with the antigen mixture format.
QLIPS
A modified shortened version of LIPS designated QLIPS (for
quick LIPS) was also employed [17]. In these assays, patient sera,
processed in a 96-well format, were combined with a 4-antigen
mixture and buffer for only 5 minutes and then incubated for
another 5 minutes with the protein A/G beads. The plates were
then washed and LU measured with the microplate luminometer
as described above.
Statistical analysis
The GraphPad Prism software (San Diego, CA) was used for
statistical analyses, including evaluating test performance by area
under the curve (AUC) [28]. Results for quantitative antibody
levels between the uninfected controls (CTRL), Ov-infected, Wb-
infected, Ll-infected and other helminth, (Ss)-infected serum
samples are reported as the geometric mean titer (GMT)695%
confidence interval (due to the typically overdispersed nature of
these data; i.e., they are not normally distributed). Correlations
among antibody responses to the four antigens tested were assessed
by the Spearman rank test (rS). The level of statistical significance
for all tests was set at P,0.05. For determining the cut-off limits
for each test two general methods were used. First, cutoff values
were derived from the mean value of the 72 uninfected control
samples plus 5 standard deviations (SD) and are indicated in the
figures. The second method, involved using cut-off values from the
two extremes of the receiver operating characteristics (ROC) curve
–those being tests that had 100% sensitivity and those tests with
100% specificity using typically highly cross-reactive Wb-infected
sera as the discriminator. ROC analysis originates from signal
detection theory as a model of how well a receiver is able to detect
a signal in the presence of noise. Its key feature is the distinction
between a true positive rate (sensitivity) and a false positive rate
(specificity), been widely used in medical applications to study the
effect of varying the threshold on the numerical outcome of a
diagnostic test. The non-parametric Mann-Whitney U test was
used for comparison of antibody titers in different groups and the
area under the receiver operator curve (AUC) was used a global
index of diagnostic accuracy [29,30]. Odds ratios, 95% confiden-
tial intervals and p-values were calculated using logistical
regression methods in order to determine the risk for having Ov-
infection using the cut-off values. For the heat map in Figure 1, the
antibody level for each serum was log10 transformed and then the
levels were color-coded as indicated by the log10 scale in the figure
legend.
Results
LIPS profiling of antibodies to four Ov antigens
Previous studies from many different laboratories have identi-
fied a large number of potential Ov antigens that might be useful
for serological screening [8]. The coding sequence for four of the
five most promising Ov antigens, Ov-Far-1 (Ov-20), Ov-API-1
(Ov-33), Ov-MSA-1 (Ov103) and Ov-CPI-1 (Ov10), were
synthetically optimized for mammalian codon usage, constructed
as C-terminal fusion with Ruc, sequence-verified, and have
GenBank accessions numbers FJ561736, FJ561737, FJ561735,
and FJ561734, respectively. Evaluation of the utility of LIPS with
these four potentially useful antigens began by testing a small
number of Ov-positive and Ov-negative sera samples (data not
shown). This panel of four recombinant Ov antigens was then
tested by LIPS with a large cohort of blinded sera that included
patients with parasitologically proven Ov infection, other filarial
infections, strongyloidiasis, and uninfected controls. Following
unmasking, we first determined the utility of these LIPS assays for
distinguishing the uninfected CTRL sera from the Ov-positive sera.
A heat map, employing log10-transformed antibody titer data, was
used to evaluate these differing antibody responses toward the four
Ov antigen panel in the 38 Ov-infected sera compared to the 72
uninfected CTRL samples (Figure 1). In addition, the sum of the
antibody titers from the four individual tests was calculated and is
also shown as part of the heat map. As seen in Figure 1, the anti-
Ov-FAR-1 and anti-Ov-API-1 antibody tests, as well as the
combined data from the four individual antibody tests, clearly
distinguished the 38 Ov-infected sera from the 72 uninfected
CTRL sera. The other two antibody tests, for Ov-MSA-1 and Ov-
CPI-1, were also useful but missed several of the Ov-positive sera.
Diagnosis of Onchocerciasis
www.plosntds.org 3 May 2009 | Volume 3 | Issue 5 | e438Figure 1. Heat map representation of patient antibody profiles to the 4 Ov antigens. The antibody levels for each serum were log10
transformed and then the levels were color-coded as indicated by the log10 scale on the left, in which signal intensities range from red to green
indicating high (red) and low (green) titers. The samples were rank ordered from highest to lowest based on the sum of the antibody titers to the 4
antigen panel. The samples on the left are from uninfected, while the samples on the right are Ov-infected sera.
doi:10.1371/journal.pntd.0000438.g001
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false positives in CTRL sera (Figure 1, top of heat map). The
results of these tests suggest that each of the four Ov antigens is
highly useful in the LIPS format for distinguishing Ov-infected sera
from uninfected control sera. Analysis of the GMT for each of the
four Ov antibody tests revealed that the Ov-infected sera had 80- to
4,000-fold higher antibody titers compared to the uninfected
control sera. For example, in normal uninfected CTRL sera the
GMT for Ov-FAR-1, Ov-API-1, Ov-MSA-1 and Ov-CPI-1 were
78 (95% CI, 42–147); 546 (95% CI, 327–914); 357 (95% CI,
232–549); and 273 (95% CI, 161–464) LU, respectively, whereas
the GMT for Ov-FAR-1, Ov-API-1, Ov-MSA-1 and Ov-CPI-1 in
the Ov-infected sera were markedly higher, with values of 288,713
(95% CI, 196,963–423,203); 190,748 (95% CI, 149,588–243,233);
49,930 (95% CI, 31,402–79,389); and 17,898 (95% CI, 8528–
37563) LU, respectively (Figure 2).
Though not obvious from the heat map, further analysis showed
that the anti-Ov-FAR-1, anti-Ov-API-1, anti-Ov-MSA-1 and Ov-
CPI-1 antibody titers correlated poorly with each other. Our
analysis showed that the antibody levels for the four different
Figure 2. LIPS detection of antibodies to 4 different Ov antigens. Each symbol represents individual samples from the 38 Ov-infected, 90 Wb,
90 Ll,2 7Ss, 72 control uninfected samples and 12 other control patients. Antibody levels in LU are plotted on the Y-axis using a log10 scale and short
solid horizontal lines indicate the geometric mean titer (GMT) for each antibody per group. The diagnostic performance related to cross-reactivity
with other filarial infections was also evaluated. As described in the text, the long solid line represents the cut-off level corresponding to 100%
sensitivity, while the long stippled line corresponds to the cut-off for 100% specificity with sera from the Wb cohort.
doi:10.1371/journal.pntd.0000438.g002
Diagnosis of Onchocerciasis
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with each other (ranging from rS=20.11 to 0.58) suggesting
marked heterogeneity in humoral responses of the Ov-infected
individuals to an individual antigen (Table 2). These results
probably reflecting individual differences in MHC Class II
haplotypes [31,32] and suggest that using multiple antigens may
be more diagnostically useful than using one or two Ov antigens.
To assess the diagnostic utility of these tests further, the
sensitivity and specificity was determined for each of these four
tests. For these calculations, the cut-off values derived from the
mean plus 5 SD of the 72 uninfected control samples were used for
Ov-FAR-1, Ov-API-1, Ov-MSA-1 and Ov-CPI-1 with values of
3,267; 13,727; 10,902; and 196,961 LU, respectively. Using these
cut-offs, the Ov-FAR-1 and Ov-API antibody tests showed 100%
sensitivity and 100% specificity in distinguishing the 38 Ov-infected
sera from the 72 uninfected control sera (calculations not shown,
but can be derived from Figure 2). ROC analysis confirmed that
both the Ov-FAR-1 and Ov-API-1 were perfect diagnostic tests for
distinguishing Ov-infected from uninfected sera with AUC values
of 1.0. The anti-Ov-MSA-1 and anti-Ov-CPI-1 antibody tests
performed less well, and showed 89% sensitivity (34/38) with 99%
specificity (71/72) and 32% sensitivity (12/38) with 99% (71/72)
specificity, respectively (calculations not shown, but can be derived
from Figure 2).
Distinguishing O. volvulus-infected sera from other filarial
and parasitic infections with the four different antigens
Because of the close phylogenetic relationship between Ov and
other filarial species and the geographic overlap of Ov infections
with co-endemic lymphatic filariasis and/or loiasis, as well as with
strongyloidiasis (known to have some cross reaction in other
serologic assays), additional sera from 90 Wb-, 90 Ll-, 27 Ss- and 12
HIE/HES/other parasite-infected sera were analyzed. As shown
in Figure 2, the antibody titer data for other filarial and intestinal
nematode-infected sera were plotted alongside the data from the
Ov-infected samples and uninfected CTRL sera that were
previously shown in Figure 1. For the anti-Ov-FAR-1 antibody
test, the Ov-infected sera showed a more than 250-fold higher
GMT of 288,713 (95% CI, 196,963–423203) LU than the Wb-, Ll-
and Ss-infected sera (see Table 3), with GMT values of 1,136 (95%
CI, 588–2196); 496 (95% CI, 213–1158); and 15 (95% CI, 3–74)
LU, respectively (Figure 2 and Table 3). Similarly, the anti-Ov-
API-1 antibody test showed a GMT of 190,748 LU (95% CI,
149,588–243,233), in the Ov-infected sera compared to the Wb-,
Ll- and Ss-infected sera, with GMTs of 3,786 (95% CI, 2545–
5633); 6,455 (95% CI, 3723–11,169); and 2,189 (95% CI, 692–
6925) LU, respectively (Figure 2). In the case of Ov-MSA-1, the
Ov-infected sera had a GMT of 49,930 (95% CI, 31,402–79,389)
LU compared to the Wb-, Ll- and Ss-infected sera with GMTs of
1282 (95% CI, 932–1765); 803 (95% CI, 545–1181); and 568
(95% CI, 194–1664) LU, respectively (Figure 2). As shown in
Table 3, significant differences between the GMT of the Ov-
infected and the Wb-, Ll-and Ss-infected sera were found for all
three antigens (P,0.001; Mann Whitney U test) as well as for the
uninfected control sera.
The least useful antigen, Ov-CPI-1, showed a GMT in the Ov-
infected sera of 17,898 (95% CI, 8528–37,563) LU compared to
GMTs of the Wb-, Ll- and Ss-infected sera with values of 2,540
(95% CI, 1465–4404); 514 (95% CI, 267–992); and 474 (95% CI,
186–1210) LU, respectively (Figure 2). A significant difference
(P,0.001; Mann Whitney U test) between the anti-Ov-CPI-1
antibody titer was still seen in the Ov-infected sera compared to the
Wb-, Ll-and Ss-infected sera (Table 3). Finally, very low antibody
titers, similar to those of the uninfected CTRL samples were
observed in the 14 other (HIE/HES/other) sera for all four of the
antigens (Figure 2 and Table 3).
To evaluate the diagnostic specificity of the different antibody
tests for detecting Ov-infection compared to the other related
filarial infections, we used cut-off values derived from the two
extremes of the ROC curve: Ov antibody tests that were 100%
sensitive or 100% specific. For each of these two cut-offs, the Wb-
infected sera were used as the negative control group (discrimi-
Table 2. Correlation of antibody titers between the four Ov
antigens with the 38 Ov-infected sera.
Comparisons rs P value
Ov-FAR-1 vs. Ov-API-1 0.58 ,0.001*
Ov-FAR-1 vs. Ov-MSA-1 0.58 ,0.001*
Ov-FAR-1 vs. Ov-CPI-1 20.11 0.532
Ov-API-1 vs. Ov-MSA-1 0.31 0.058
Ov-API-1 vs. Ov-CPI-1 0.02 0.889
Ov-MSA-1 vs. Ov CPI-1 0.27 0.103
*P,0.05 (significant).
doi:10.1371/journal.pntd.0000438.t002
Table 3. Antibody titer characteristics for the Ov antigens.
Antigen Sera GMT (95% CI) P
a AUC*
Ov-FAR-1 Ov 288,713 (196,963–423,203)
Ov-FAR-1 Wb 1136 (588–2196) ,0.0001 0.98
Ov-FAR-1 Ll 496 (213–1158) ,0.0001 0.96
Ov-FAR-1 Ss 13 (3–64) ,0.0001 0.99
Ov-FAR-1 CTRL 78 (42–147) ,0.0001 1.00
Ov-FAR-1 Other 147 (30–727) ,0.0001 1.00
Ov-API-1 Ov 190,748 (149,588– 243,233)
Ov-API-1 Wb 3786 (2545–5633) ,0.0001 0.97
Ov-API-1 Ll 6455 (3723–11189) ,0.0001 0.94
Ov-API-1 Ss 2189 (692–6925) ,0.0001 1.00
Ov-API-1 CTRL 546 (327–914) ,0.0001 1.00
Ov-API-1 Others 103 (14–745) ,0.0001 1.00
Ov-MSA-1 Ov 49,930 (31,402–79,389)
Ov-MSA-1 Wb 1282 (932–1765) ,0.0001 0.96
Ov-MSA-1 Ll 803 (545–1181) ,0.0001 0.96
Ov-MSA-1 Ss 568 (194–1664) ,0.0001 0.96
Ov-MSA-1 CTRL 357 (232–549) ,0.0001 0.99
Ov-MSA-1 Others 610 (294–1269) ,0.0001 0.98
Ov-CPI-1 Ov 17,898 (8528– 37,563)
Ov-CPI-1 Wb 2540 (1465–4404) 0.0002 0.71
Ov-CPI-1 Ll 514 (267–992) ,0.0001 0.93
Ov-CPI-1 Ss 474 (186–1210) ,0.0001 0.84
Ov-CPI-1 CTRL 273 (161–464) ,0.0001 0.87
Ov-CPI-1 Others 670 (284–1577) ,0.0001 0.89
P
a –For the comparisons between the antibody titers in the Ov-infected sera
with each of the other sera groups by Mann Whitney U test.
*AUC-area under the receiver operator curve was used as a global index of
diagnostic accuracy [29,30].
doi:10.1371/journal.pntd.0000438.t003
Diagnosis of Onchocerciasis
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without the potential for having Ov infection and were likely to be
potentially among the most cross reactive. The most informative
test, detecting anti-Ov-FAR-1 antibodies with a low end cut-off of
10,393 LU, showed 100% sensitivity and yielded 76% (68/90),
74% (71/90), 82% (22/27), and 100% (72/72) specificity with the
Wb-, Ll-, Ss-infected sera and the CTRL sera, respectively
(Figure 2A, solid horizontal line). In contrast, a high end cut-off
of 156,123 LU for Ov-FAR-1 had 74% (28/38) sensitivity for
detecting Ov-infected sera but markedly higher specificity values of
100% (90/90), 94% (85/90), 100% (27/27), and 100% (72/72)
specificity with the Wb-, Ll-, Ss-infected sera and the CTRL sera,
respectively (Figure 2A, dashed horizontal line). In the case, of Ov-
API-1, only the low end cut-off had practical diagnostic value. For
Ov-API-1, the low end cut-off of 23,945 LU showed 100% (38/38)
sensitivity in detecting Ov-infected sera with specificity values of
83% (75/90), 68% (61/90), 93% (26/27) and 100% (72/72) with
the Wb-, Ll-, Ss-infected sera and the CTRL sera, respectively
(Figure 2B). For Ov-MSA-1, only the high end cut-off (41,700 LU)
was diagnostically useful and showed 71% sensitivity (27/38) in
detecting Ov-infected sera with specificity values of 99% (89/90)
with Ll and 100% with the Wb- (90/90), Ss- (27/27) infected sera,
and CTRL (72/72) sera (Figure 2C). While the anti-Ov-CPI-1
antibody tests showed markedly higher GMT in the Ov-infected
sera, this test had relatively little practical diagnostic utility when
these strict cut-off criteria were used (Figure 2D). In summary,
these results suggest that each of the four Ov antigens showed
preferential immunoreactivity with Ov-infected sera compared to
the other filarial and intestinal nematode-infected sera. For all four
Ov assays, the LU values of the other HIE/HES sera were all
similar to or less than the CTRL sera (Table 3).
Antibody responses to a mixture of four O. volvulus
antigens
Having previously shown that combining two different Ss
antigens had improved performance over the individual tests [16],
we evaluated the diagnostic performance of using a four-Ov
antigen mixture to assess antibody levels in the same Ov-, Wb-, Ll-,
Ss-infected sera, CTRL sera, and other conditions (HIE/HES)
tested by the individual assays (Figure 3A). The results of the four-
antigen mixture showed a GMT for the Ov-infected sera of
2,107,000 (95% CI, 1,557,000–2,851,000) LU, which was over
1,000 times higher than the GMT of 1,938 (95% CI, 1,032–3639)
LU for the CTRL uninfected sera. Additionally, the GMTs of the
antigen mixture with the other infected sera showed much lower
values of 33,232 (95% CI, 20,875–52,902); 33,843 (95% CI,
21,887–52,331); 4,307 (95% CI, 962–19,275) and 2,993(95% CI,
541–16,556) LU for the Wb-, Ll-, Ss-infected and the other HIE/
HES sera, respectively (Figure 3A). The GMT to the cocktail in
the Ov-infected individuals were statistically significantly higher
than those of the uninfected and other filariasis- or strongyloidi-
asis-infected sera (P,0.0001). Finally, the values from the four-
antigen mixture also closely correlated with the sum of the values
from the four separate tests (rS=0.93, P,0.00001) suggesting that
in the LIPS format the resulting antibody titer values are highly
reproducible under these two different assay conditions.
Cut-off values were next derived from the two extremes of the
ROC curve and employed to evaluate the diagnostic performance
of this four-antigen cocktail test. With the low end cut-off of
132,785 LU, the four-antigen mixture test showed 100%
sensitivity and yielded 78% (70/90), 73% (66/90), 85% (23/27),
100% (72/72) and 100% (12/12) specificity with the Wb-, Ll-, Ss-
infected sera and the CTRL and other (HIE/HES) sera,
Figure 3. A four Ov antigen panel used in the standard 2 hour or QLIPS format shows 100% sensitivity and 100% specificity. Each
symbol represents individual samples from the 38 Ov-infected, 90 Wb,9 0Ll,2 7Ss, 72 control uninfected samples and 12 other control patients. These
LIPS tests were either evaluated as a mixture in the standard format (A) or with QLIPS (B). As shown, both tests showed 100% sensitivity and 100%
specificity in distinguishing the uninfected from the Ov-infected sera. The diagnostic performance related to cross-reactivity with other filarial
infections was also evaluated. As described in the text, the long solid line represents the cut-off level corresponding to 100% sensitivity, while the
long stippled line corresponds to the cut-off for 100% specificity with sera from the Wb cohort.
doi:10.1371/journal.pntd.0000438.g003
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million LU showed 74% (28/38) sensitivity and had 100%
specificity with all the different sera categories (Figure 3A, dashed
line). Based on this performance, these results suggest that this
four-antigen mixture format is a simple and useful test for the
diagnosis of Ov infection and for distinguishing most of the Ov-
infected sera from other filarial and non-filarial helminth infected
samples.
Rapid QLIPS testing using a four antigen mixture
Previously we have used a single antigen in a quick LIPS format
(QLIPS), in which the two incubation steps of 1 hour each are
reduced to 5 minutes each to assess Ll infection more efficiently
[17]. Here we tested the diagnostic performance of the QLIPS
format using the mixture of four Ov antigens with the different
infected and uninfected sera. As shown in Figure 3B, the GMT
using the QLIPS format was 460,337 (95% CI, 325,109–651,814)
LU for Ov-infected sera, which was 1,000-fold higher than the
GMT of the CTRL sera of 273 (95% CI, 128–580) LU.
Compared to the Ov-infected sera, other non-Ov filarial-infected
sera and sera from those with strongyloidiasis showed much lower
GMT values of 4,898 (95% CI, 2804–8558) for Wb; 2,656 (95%
CI, 1517–4648) for Ll and 413 (95% CI, 120–1416) for Ss.I t
should be noted that while the overall GMT values from the
QLIPS format were approximately 10-fold lower with each of the
different sera sub-groups than that with the standard format
(compare Figure 3A and 3B), the overall pattern of immunore-
activity of the two assay formats tracked each other well.
Nevertheless, with the QLIPS format many more of the non-Ov-
infected sera showed antibody values of zero (Figure 3B).
With the low end cut-off of 30,000 LU, QLIPS testing showed
100% sensitivity and yielded 76% (68/90), 84% (76/90), 93% (25/
27), 100% (72/72), and 100% (12/12) specificity with the Wb-, Ll-,
Ss- infected, CTRL, and other (HIE/HES) sera, respectively
(Figure 3B, solid line and Table 4). From the high end cut-off of
203,199 LU, the QLIPS format showed 79% (30/38) sensitivity
and had 100% specificity with all the sera categories (Figure 3B,
dashed line and Table 4). Odd ratios and 95% CI were calculated
in order to determine the relative risk for having Ov-infection at a
given cut-off. Using a cut-off of 30,000 LU with the QLIPS
format, the odds ratio for Ov-infected versus Wb-infected was 249
(95% CI, 15–4,227) and even higher, 406 (95% CI, 24–6,998), for
Ll. Thus the presence of antibody titers above 30,000 LU in the
QLIPS provides not only a perfect test to distinguish Ov-infected
from uninfected sera (100% sensitivity and 100% specificity), but
also showed relatively high specificity for discriminating Ov
infection from other often cross-reactive filarial infections
(Table 4). For comparison, the cut-off of 132,785 LU in the
standard 2-hour LIPS format yielded a similar odds ratio for Ov-
infected versus Wb-infected of 265 (95% CI, 16–4,504) and had an
odds ratio value of 209 (95% CI, 12–3,537) for Ll. As shown in
Table 4, the presence of antibody titers above the cut-off in the
standard 2-hour format had a slightly lower performance than that
of the QLIPS format for the Ll- and Ss-infected sera. These results
suggest that the QLIPS format using this four-antigen mixture is as
good as or slightly better than the four-antigen mixture used in the
standard format for distinguishing Ov from other filariases and
strongyloidiasis.
Discussion
This study demonstrates that LIPS can detect O. volvulus
infection by antibody profiling with high diagnostic sensitivity and
specificity using a panel of four antigens. The high-throughput,
partially automated LIPS and QLIPS formats used here make
these approaches highly feasible for screening large numbers of
serum samples and/or for rapid field testing. While these Ov
antigens have been used individually and in combinations as
cocktails for screening purposes in ELISA formats, the LIPS tests
offered many advantages over conventional ELISA and Western
blotting. Some of these advantages include the simple and rapid
production of antigens, detection of a large dynamic range of
antibody titers without dilution of samples, and the rapid format of
the assays that provide superior performance. The robust
detection of all four antigens in the LIPS format is likely
attributable to the detection of more conformational-specific
epitopes. Interestingly, another known recombinant Ov antigen,
Ov-16 [7] that has performed well in both diagnostic [13] and
field-based [12] assays was not immunogenic in the LIPS format
likely due to protein misfolding in mammalian cells. Nevertheless,
based on the performance of these four Ov antigens, it is likely that
further modifications of these LIPS tests, such as the addition of
new Ov antigens, the leaving out of potentially less useful antigens
(e.g. Ov-CPI-1), and the adjusting of cut-off values may further
simplify testing and improve assay performance.
Similar to our previous published results with S. stercoralis [16]
and L. loa [17], all four Ov antigens tested here showed a similar
dynamic range in O. volvulus-positive sera and relatively similar
background binding values in uninfected control sera. It should be
noted that several of the Ov antigens used here have homologs in
other filariae. For example, the 162 amino acid Ov-FAR-1
fragment has approximately 80% similarity with related proteins
from Brugia malayi, Wuchereria bancrofti (Wb), and Loa loa [33].
Nevertheless, the ability of using these antigens to preferentially
distinguish Ov infection from other related filarial infections is
consistent with other reports [24,34] and may be further enhanced
in the LIPS format due to the detection of many more
conformational epitopes. In detecting onchocerciasis, the most
informative antigen was Ov-FAR-1, followed by Ov-API-1, Ov-
MSA-1 and lastly Ov-CPI-1. The ability to use an antigen mixture
in the standard LIPS format or QLIPS format is very convenient
as it simplifies data collection and analysis. Furthermore, the
values obtained using the sum of the four individual Ov tests and
those using the antigen mixture closely matched each other,
suggesting that the detected antibody titers are highly reproducible
regardless of LIPS assay conditions used. In general, increasing the
number of antigens within a mixture is generally a favorable
condition if each member antigen has a comparable low
Table 4. Sensitivity, specificity, and odds ratio for the four-
antigen mixture determined by LIPS and QLIPS.
Comparisons Sensitivity Specificity Odds ratio (95% CI) P value
LIPS.132,785
Ov vs CTRL 100% 100%
Ov vs Wb 100% 78% 265 (16–4,504) ,0.0001
Ov vs Ll 100% 73% 209 (12–3,537) ,0.0001
Ov vs Ss 100% 85% 402 (20–7,816) ,0.0001
QLIPS.30,000
Ov vs CTRL 100% 100%
Ov vs Wb 100% 76% 249 (15–4,227) ,0.0001
Ov vs Ll 100% 84% 406 (24–6,998) ,0.0001
Ov vs Ss 100% 93% 785 (36–17,060 ,0.0001
doi:10.1371/journal.pntd.0000438.t004
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more than one antigen is immobilized and the alternative is to
employ complicated multi-epitope hybrid molecules from different
Ov antigens [14,15]. Luminex technology can also be used in
screening panels of antigens for diagnosis, but require much more
expensive equipment and thus has little value for detection of
onchocerciasis in most non-hospital or research settings. Consis-
tent with previous studies successfully using cocktails of Ov antigens
for serological diagnosis [9,10,11], the positive results obtained
here by LIPS with the four Ov antigen mixture supports our
previous findings that mixtures of antigens provide more
discrimination between infected and uninfected individuals
irrespective of the infection being tested [16,35]. Thus, this
general approach of antigen cocktails is likely to be useful for the
diagnosis of many other infections.
The QLIPS format performed in less than 15 minutes per 94
samples showed equally promising results for the diagnosis of Ov-
infection as the standard 2.5-hour LIPS test. Compared to the
standard LIPS format, QLIPS showed an approximately ten-fold
drop in overall signal in the serum samples but with no change in
sensitivity and specificity. In this QLIPS format, all of the Ov-
infected sera showed positive signals compared to the uninfected
sera resulting in 100% sensitivity and 100% specificity. The
increased specificity of the QLIPS format over the standard LIPS
format for distinguishing Ll- and Ss-infected sera may be related to
the failure of potential low affinity antibodies from individuals with
related (non-Onchocerca) infections to bind as readily during this
short incubation period resulting in much lower signals for these
potentially cross-reactive sera. Since we did not test all possible
combinations of antigens in the QLIPS format, it is also possible
that other antigen combinations might improve performance. As
more genomic information is integrated with antigen screening,
new immunogenic Ov antigens may be identified that might be
unique to O. volvulus. If such antigens are identified, the
incorporation of these proteins may markedly improve the
specificity of these LIPS tests. Though not detailed here, the
application of LIPS for quantitative analysis of serial antibody
responses to a panel of Ov antigens could potentially be useful for
monitoring response to drug therapy as seen previously in another
infection [16] and for sub-stratifying patient subtypes [27].
Compared to other assays formats LIPS showed increased
sensitivity and can be performed much more quickly. For
example, a field-applicable diagnostic card immunoassay based
on a recombinant antigen, Ov-16, showed 80% sensitivity for
detecting Ov-infected sera [12,13], while an ELISA employing a
recombinant hybrid Ov protein showed 93% sensitivity [14,15]. In
these and other studies, issues related to cross-reactivity with other
filarial-infected sera such as with Wb and Ll were not studied with
a large enough group of samples and generally showed poorer
discrimination of Ov-infected sera from these other infections.
While the Ov-16 card assay can be performed quickly, other
conventional ELISAs require 5–24 hours for completion. In
addition to experimental methodology used here, additional LIPS
assay formats including microtiter well formats with protein A/G-
coated microtiters or gravity filter devices could be utilized. These
assays could be performed very inexpensively and be could be
employed under less than ideal laboratory conditions.
Our results suggest that the four antigen LIPS/QLIPS has great
potential as a tool for early monitoring of changes in the
transmission of O. volvulus and the recrudescence of onchocerciasis.
Like the IgG4-based Ov16 ELISA that is already in use [5], the
four-antigen LIPS/QLIPS increases the sensitivity of the assay to
100% without loss of specificity. Such measures will enhance the
antibody screening methodology and could provide additional
levels of confidence when decisions about cessation of control
measures are being made.
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